drugset / Trial / NCT01523275
Study of Mitomycin-C Application in Laryngotracheal Stenosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.
Timeline
- Start
- 2012-08
- Primary completion
- 2018-02
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitomycin C | Other / unclassified | 0.4 mg/ml | Topical |